Menu
Not yet recruiting NCT06505148

Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?

Phase IV Interventional Pediatric Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Acetaminophen, Ibuprofen.
Who it may be relevant to
Registry conditions: Pediatric Disorder. Basic parameters: 3 years — 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

To examine the difference in pain control in the pediatric general surgery population alternating acetaminophen and Ibuprofen q 3 hours vs giving them simultaneous combination therapy around the clock.

Detailed description

The purpose of the study is to compare the difference in pain control in the pediatric general surgery population of those who receive alternating acetaminophen and ibuprofen every 3 hours to those who receive acetaminophen and ibuprofen combined therapy around the clock. Additionally, to investigate the difference in parent adherence to pain treatment plans between the alternating group from the combined group.

Interventions

  • Drug Acetaminophen
    administered alternatively with other drug
  • Drug Ibuprofen
    administered alternatively with other drug

Primary outcome measures

  • Faces, Legs, Activity, Cry, and Consolability (FLACC) pain assessment scale. [Time frame: 24, 48, and 72 hours after surgery]
  • Pain Visual Analog Scale (VAS) [Time frame: 24, 48, and 72 hours after surgery]
  • Numeric Pain Rating Scale (NPRS) [Time frame: 24, 48, and 72 hours after surgery]
Secondary outcome measures (1)
  • Parent/ guardian adherence [Time frame: 72 hours after surgery]

Eligibility criteria

Inclusion criteria

  • Age group: 3 years to 18 years
  • General surgery service (hernia, appendectomy, chole, circumcision, wounds, vacs, implanted central line, etc.)

Exclusion criteria

  • Patients who are allergic to acetaminophen and/or ibuprofen
  • Patients being evaluated by SANE or evaluated for nonaccidental trauma
  • Patients admitted post-op

The study will take place at McLane Children's Hospital Temple Market. Patients who are pregnant.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • Baylor Scott & White Health Temple Market — Temple

Identifiers

NCT: NCT06505148 · 024-301

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗